Overview

A Study Comparing the Withdrawal of Steroids or Tacrolimus in Kidney Transplant Recipients

Status:
Completed
Trial end date:
2007-10-01
Target enrollment:
Participant gender:
Summary
This study evaluates two different immunosuppression drug regimens in patients with a recent kidney transplant. Patients initially received a regimen of Sirolimus, Tacrolimus and Prednisone and then randomized to discontinue either Tacrolimus or Prednisone.
Phase:
Phase 4
Details
Lead Sponsor:
Wyeth is now a wholly owned subsidiary of Pfizer
Treatments:
Everolimus
Prednisone
Sirolimus
Tacrolimus